Appili Therapeutics Inc. (APLIF)
Appili Therapeutics Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Halifax, NS, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $132,366. Its beta of -0.21 implies it has historically moved less than the broad market.
Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Appili Therapeutics Inc. is most often compared with the following Healthcare names: